Natco launches Hepatitis C drug in Nepal

Natco launches Hepatitis C drug in Nepal
Highlights

Natco launches Hepatitis C drug in Nepal. City based Natco Pharma has launched the first licensed generic version of Hepatitis C medicine under its brand name Hepcinat LP in Nepal.

Hyderabad: City based Natco Pharma has launched the first licensed generic version of Hepatitis C medicine under its brand name Hepcinat LP in Nepal. The drug is used in the treatment of chronic hepatitis C infection in adults. Natco has priced the product at Rs 25,000 for a bottle of 28 tablets in Nepal.

Licensed from Gilead Sciences earlier this year, Hepcinat LP is a two-drug fixed dose combination product containing Ledipasvir and Sofosbuvir in a single tablet. It had signed non-exclusive licensing agreements with the US-based Gilead Sciences, Inc. to sell the drug in India and other developing countries.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
More Stories


Top